WO2002002610A3 - Molecules de circulation et de secretion - Google Patents
Molecules de circulation et de secretion Download PDFInfo
- Publication number
- WO2002002610A3 WO2002002610A3 PCT/US2001/020704 US0120704W WO0202610A3 WO 2002002610 A3 WO2002002610 A3 WO 2002002610A3 US 0120704 W US0120704 W US 0120704W WO 0202610 A3 WO0202610 A3 WO 0202610A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sat
- secretion
- trafficking molecules
- provides
- trafficking
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01952303A EP1294884A2 (fr) | 2000-06-29 | 2001-06-28 | Molecules de secretion et de transport |
AU2001273070A AU2001273070A1 (en) | 2000-06-29 | 2001-06-28 | Secretion and trafficking molecules |
JP2002507862A JP2004528002A (ja) | 2000-06-29 | 2001-06-28 | 分泌分子および輸送分子 |
CA002410679A CA2410679A1 (fr) | 2000-06-29 | 2001-06-28 | Molecules de circulation et de secretion |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21546500P | 2000-06-29 | 2000-06-29 | |
US60/215,465 | 2000-06-29 | ||
US23938400P | 2000-10-10 | 2000-10-10 | |
US60/239,384 | 2000-10-10 | ||
US25363900P | 2000-11-28 | 2000-11-28 | |
US60/253,639 | 2000-11-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002002610A2 WO2002002610A2 (fr) | 2002-01-10 |
WO2002002610A3 true WO2002002610A3 (fr) | 2002-09-19 |
Family
ID=27396128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/020704 WO2002002610A2 (fr) | 2000-06-29 | 2001-06-28 | Molecules de circulation et de secretion |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1294884A2 (fr) |
JP (1) | JP2004528002A (fr) |
AU (1) | AU2001273070A1 (fr) |
CA (1) | CA2410679A1 (fr) |
WO (1) | WO2002002610A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002053591A1 (fr) * | 2000-12-30 | 2002-07-11 | Lion Bioscience Ag | Cofacteur de recepteur nucleaire mammalien cf12 et ses procedes d'utilisation |
AU2002234595A1 (en) * | 2000-12-30 | 2002-07-16 | Lion Bioscience Ag | Mammalian nuclear receptor cofactor cf11 and methods of use |
WO2003093466A1 (fr) * | 2002-05-02 | 2003-11-13 | Bayer Healthcare Ag | Proteine humaine associee au rhomboide |
WO2005090569A1 (fr) * | 2004-03-24 | 2005-09-29 | The Council Of The Queensland Institute Of Medical Research | Cancer et acides nucleiques et proteines de testicule vsm1 et vsm2, et leurs utilisations |
AU2009270826B2 (en) * | 2008-07-18 | 2012-10-04 | University Of Medicine And Dentistry Of New Jersey | Compositions comprising MG29 nucleic acids, polypeptides and associated methods of use |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993025699A1 (fr) * | 1992-06-11 | 1993-12-23 | The Regents Of The University Of California | Proteines de transport a travers la membrane de vesicules |
WO1998037094A2 (fr) * | 1997-02-24 | 1998-08-27 | Genetics Institute, Inc. | Proteines secretees et polynucleotides les codant |
WO1999016875A1 (fr) * | 1997-09-30 | 1999-04-08 | Yale University | Procede servant a effectuer le controle selectif de la presence d'une proteine de membrane et de la secretion de proteines dans des cellules eucaryotes |
WO2000012703A2 (fr) * | 1998-08-27 | 2000-03-09 | Incyte Pharmaceuticals, Inc. | Molecules associees au transport de proteines |
EP1033401A2 (fr) * | 1999-02-26 | 2000-09-06 | Genset | Marqueurs de séquence exprimées et protéines humaines codées |
WO2000056767A1 (fr) * | 1999-03-19 | 2000-09-28 | Human Genome Sciences, Inc. | Proteines humaines secretees (46) |
-
2001
- 2001-06-28 AU AU2001273070A patent/AU2001273070A1/en not_active Abandoned
- 2001-06-28 EP EP01952303A patent/EP1294884A2/fr not_active Withdrawn
- 2001-06-28 WO PCT/US2001/020704 patent/WO2002002610A2/fr not_active Application Discontinuation
- 2001-06-28 CA CA002410679A patent/CA2410679A1/fr not_active Abandoned
- 2001-06-28 JP JP2002507862A patent/JP2004528002A/ja active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993025699A1 (fr) * | 1992-06-11 | 1993-12-23 | The Regents Of The University Of California | Proteines de transport a travers la membrane de vesicules |
WO1998037094A2 (fr) * | 1997-02-24 | 1998-08-27 | Genetics Institute, Inc. | Proteines secretees et polynucleotides les codant |
WO1999016875A1 (fr) * | 1997-09-30 | 1999-04-08 | Yale University | Procede servant a effectuer le controle selectif de la presence d'une proteine de membrane et de la secretion de proteines dans des cellules eucaryotes |
WO2000012703A2 (fr) * | 1998-08-27 | 2000-03-09 | Incyte Pharmaceuticals, Inc. | Molecules associees au transport de proteines |
EP1033401A2 (fr) * | 1999-02-26 | 2000-09-06 | Genset | Marqueurs de séquence exprimées et protéines humaines codées |
WO2000056767A1 (fr) * | 1999-03-19 | 2000-09-28 | Human Genome Sciences, Inc. | Proteines humaines secretees (46) |
Non-Patent Citations (4)
Title |
---|
DATABASE EMBL SEQUENCE DATABASE Hinxton, UK; 18 June 2000 (2000-06-18), R.H. WATERSTON: "Homo sapiens chromosome 2 xlone RP11-803F15", XP002193349 * |
DATABASE EMBL SEQUENCE DATABASE Hinxton, UK; 23 September 1999 (1999-09-23), J.E. SULSTON AND R. WATERSON: "Homo sapiens BAC clone RP11-395N3 from 2, complete sequence", XP002193417 * |
DATABASE GENSEQ DATABASE NCBI, US; 6 October 2000 (2000-10-06), GENSET: "Human secreted proteins 5' EST , SEQ ID No: 23886", XP002193416 * |
DATABASE GENSEQ SEQUENCE DATABASE Hinxton, UK; 2 February 2001 (2001-02-02), HUMAN GENOME SCI INC: "Human secreted protein sequence #39", XP002193348 * |
Also Published As
Publication number | Publication date |
---|---|
EP1294884A2 (fr) | 2003-03-26 |
WO2002002610A2 (fr) | 2002-01-10 |
JP2004528002A (ja) | 2004-09-16 |
AU2001273070A1 (en) | 2002-01-14 |
CA2410679A1 (fr) | 2002-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000070049A3 (fr) | Molecules de signalisation extracellulaires | |
WO2001012662A3 (fr) | Proteines associees a la membrane | |
WO2002046383A3 (fr) | Molecules de modification et de maintenance proteiques | |
WO2002063005A3 (fr) | Molecules associees a des lipides | |
WO2002038602A3 (fr) | Proteines secretees | |
WO2001098354A3 (fr) | Recepteurs | |
WO2002048337A3 (fr) | Proteines secretees | |
WO2001098353A3 (fr) | Proteines secretees | |
WO2001072777A3 (fr) | Facteurs de transcription | |
WO2001079291A3 (fr) | Proteines secretees | |
WO2002026950A3 (fr) | Transferases | |
WO2002034783A3 (fr) | Proteines transmembranaires | |
WO2001032888A3 (fr) | Molecules humaines de la transferase | |
WO2001096546A3 (fr) | Proteine-phosphatases | |
WO2001085942A3 (fr) | Proteines associees au cytosquelette | |
WO2002010363A3 (fr) | Proteines phosphatases | |
WO1999041373A3 (fr) | Molecules humaines associees au transport | |
WO2000065054A3 (fr) | Proteines humaines associees aux membranes | |
WO2002002610A3 (fr) | Molecules de circulation et de secretion | |
WO2002026982A3 (fr) | Proteines secretees | |
WO2002024924A3 (fr) | Proteine phosphatases | |
WO2002066646A3 (fr) | Proteines associees a la neurotransmission | |
WO2001092527A3 (fr) | Regulateurs de l'apoptose | |
WO2002026998A3 (fr) | Hydrolases | |
WO2001051636A3 (fr) | Proteines secretees |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2410679 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2002 507862 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001952303 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001952303 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10311626 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001952303 Country of ref document: EP |